254 related articles for article (PubMed ID: 17626073)
1. Epstein-Barr virus BHRF1 micro- and stable RNAs during latency III and after induction of replication.
Xing L; Kieff E
J Virol; 2007 Sep; 81(18):9967-75. PubMed ID: 17626073
[TBL] [Abstract][Full Text] [Related]
2. Editing of Epstein-Barr virus-encoded BART6 microRNAs controls their dicer targeting and consequently affects viral latency.
Iizasa H; Wulff BE; Alla NR; Maragkakis M; Megraw M; Hatzigeorgiou A; Iwakiri D; Takada K; Wiedmer A; Showe L; Lieberman P; Nishikura K
J Biol Chem; 2010 Oct; 285(43):33358-33370. PubMed ID: 20716523
[TBL] [Abstract][Full Text] [Related]
3. Quantitative studies of Epstein-Barr virus-encoded microRNAs provide novel insights into their regulation.
Amoroso R; Fitzsimmons L; Thomas WA; Kelly GL; Rowe M; Bell AI
J Virol; 2011 Jan; 85(2):996-1010. PubMed ID: 21068248
[TBL] [Abstract][Full Text] [Related]
4. cis-Acting effects on RNA processing and Drosha cleavage prevent Epstein-Barr virus latency III BHRF1 expression.
Xing L; Kieff E
J Virol; 2011 Sep; 85(17):8929-39. PubMed ID: 21697496
[TBL] [Abstract][Full Text] [Related]
5. The Epstein-Barr virus miR-BHRF1 microRNAs regulate viral gene expression in cis.
Poling BC; Price AM; Luftig MA; Cullen BR
Virology; 2017 Dec; 512():113-123. PubMed ID: 28950226
[TBL] [Abstract][Full Text] [Related]
6. Virus and cell RNAs expressed during Epstein-Barr virus replication.
Yuan J; Cahir-McFarland E; Zhao B; Kieff E
J Virol; 2006 Mar; 80(5):2548-65. PubMed ID: 16474161
[TBL] [Abstract][Full Text] [Related]
7. The BHLF1 Locus of Epstein-Barr Virus Contributes to Viral Latency and B-Cell Immortalization.
Yetming KD; Lupey-Green LN; Biryukov S; Hughes DJ; Marendy EM; Miranda JL; Sample JT
J Virol; 2020 Aug; 94(17):. PubMed ID: 32581094
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr Virus miR-BHRF1-3 Targets the BZLF1 3'UTR and Regulates the Lytic Cycle.
Fachko DN; Chen Y; Skalsky RL
J Virol; 2022 Feb; 96(4):e0149521. PubMed ID: 34878852
[TBL] [Abstract][Full Text] [Related]
9. EBV-miR-BHRF1-2 targets PRDM1/Blimp1: potential role in EBV lymphomagenesis.
Ma J; Nie K; Redmond D; Liu Y; Elemento O; Knowles DM; Tam W
Leukemia; 2016 Mar; 30(3):594-604. PubMed ID: 26530011
[TBL] [Abstract][Full Text] [Related]
10. EBV encoded miR-BHRF1-1 potentiates viral lytic replication by downregulating host p53 in nasopharyngeal carcinoma.
Li Z; Chen X; Li L; Liu S; Yang L; Ma X; Tang M; Bode AM; Dong Z; Sun L; Cao Y
Int J Biochem Cell Biol; 2012 Feb; 44(2):275-9. PubMed ID: 22108199
[TBL] [Abstract][Full Text] [Related]
11. The Epstein-Barr virus miR-BHRF1-1 targets RNF4 during productive infection to promote the accumulation of SUMO conjugates and the release of infectious virus.
Li J; Callegari S; Masucci MG
PLoS Pathog; 2017 Apr; 13(4):e1006338. PubMed ID: 28414785
[TBL] [Abstract][Full Text] [Related]
12. An Epstein-Barr Virus MicroRNA Blocks Interleukin-1 (IL-1) Signaling by Targeting IL-1 Receptor 1.
Skinner CM; Ivanov NS; Barr SA; Chen Y; Skalsky RL
J Virol; 2017 Nov; 91(21):. PubMed ID: 28794034
[TBL] [Abstract][Full Text] [Related]
13. The expression of a viral microRNA is regulated by clustering to allow optimal B cell transformation.
Haar J; Contrant M; Bernhardt K; Feederle R; Diederichs S; Pfeffer S; Delecluse HJ
Nucleic Acids Res; 2016 Feb; 44(3):1326-41. PubMed ID: 26635399
[TBL] [Abstract][Full Text] [Related]
14. Three restricted forms of Epstein-Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cells.
Kelly GL; Milner AE; Baldwin GS; Bell AI; Rickinson AB
Proc Natl Acad Sci U S A; 2006 Oct; 103(40):14935-40. PubMed ID: 17001014
[TBL] [Abstract][Full Text] [Related]
15. The members of an Epstein-Barr virus microRNA cluster cooperate to transform B lymphocytes.
Feederle R; Haar J; Bernhardt K; Linnstaedt SD; Bannert H; Lips H; Cullen BR; Delecluse HJ
J Virol; 2011 Oct; 85(19):9801-10. PubMed ID: 21752900
[TBL] [Abstract][Full Text] [Related]
16. EBNA-1 sequence variations reflect active EBV replication and disease status or quiescent latency in lymphocytes.
Wang JT; Sheeng TS; Su IJ; Chen JY; Chen MR
J Med Virol; 2003 Mar; 69(3):417-25. PubMed ID: 12526054
[TBL] [Abstract][Full Text] [Related]
17. An Epstein-Barr virus anti-apoptotic protein constitutively expressed in transformed cells and implicated in burkitt lymphomagenesis: the Wp/BHRF1 link.
Kelly GL; Long HM; Stylianou J; Thomas WA; Leese A; Bell AI; Bornkamm GW; Mautner J; Rickinson AB; Rowe M
PLoS Pathog; 2009 Mar; 5(3):e1000341. PubMed ID: 19283066
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus (EBV) nuclear antigen leader protein (EBNA-LP) forms complexes with a cellular anti-apoptosis protein Bcl-2 or its EBV counterpart BHRF1 through HS1-associated protein X-1.
Matsuda G; Nakajima K; Kawaguchi Y; Yamanashi Y; Hirai K
Microbiol Immunol; 2003; 47(1):91-9. PubMed ID: 12636258
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus growth/latency III program alters cellular microRNA expression.
Cameron JE; Fewell C; Yin Q; McBride J; Wang X; Lin Z; Flemington EK
Virology; 2008 Dec; 382(2):257-66. PubMed ID: 18950829
[TBL] [Abstract][Full Text] [Related]
20. A viral microRNA cluster strongly potentiates the transforming properties of a human herpesvirus.
Feederle R; Linnstaedt SD; Bannert H; Lips H; Bencun M; Cullen BR; Delecluse HJ
PLoS Pathog; 2011 Feb; 7(2):e1001294. PubMed ID: 21379335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
